Colgate-Palmolive (CL), mostly owned by institutional shareholders, has demonstrated consistent performance with a respectable 46% return over the last five years and a 40% stock rise. Despite occasional underperformance compared to competitors and certain downgrades, the company's steady profits attracted significant backing from Centre Asset Management, Confluence Investment Management, M&T Bank Corp, and more. While it was reviewed as a solid growth stock, some insiders demonstrated hesitancy by selling their shares. Factors contributing to CL's growth include strong organic sales and favourable Q3 earnings, which aligned with Wall Street's estimates and led to a raised outlook for 2024. Attention is also drawn to the company's commitment to digital advertising, its inclusion on UBS’s List of Stocks for AI, Growth and Low Rates Era, and its proactive pricing and productivity efforts despite weakened North American sales. Several publications suggested CL as an attractive option for steady income or a safe long-term investment. However, some recommend caution due to Stifel’s downgrade and potential risks associated with having 84%-85% institutional ownership.
Colgate-Palmolive Company CL News Analytics from Fri, 26 Apr 2024 07:00:00 GMT to Fri, 03 Jan 2025 15:59:15 GMT -
Rating 7
- Innovation 2
- Information 6
- Rumor -2
